The influence of 150-cavity binders on the dynamics of influenza A neuraminidases as revealed by molecular dynamics simulations and combined clustering.
Neuraminidase inhibitors are the main pharmaceutical agents employed for treatments of influenza infections. The neuraminidase structures typically exhibit a 150-cavity, an exposed pocket that is adjacent to the catalytic site. This site offers promising additional contact points for improving poten...
Main Authors: | Kyle T Greenway, Eric B LeGresley, B Mario Pinto |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3609799?pdf=render |
Similar Items
-
Locking the 150-cavity open: in silico design and verification of influenza neuraminidase inhibitors.
by: Nanyu Han, et al.
Published: (2013-01-01) -
Plasticity of 150-loop in influenza neuraminidase explored by Hamiltonian replica exchange molecular dynamics simulations.
by: Nanyu Han, et al.
Published: (2013-01-01) -
Molecular modelling -- Lead compound design in H5N1 avian influenza neuraminidase 150 cavity
by: Bor-Yeu Hsu, et al.
Published: (2008) -
Molecular dynamics simulations suggest that electrostatic funnel directs binding of Tamiflu to influenza N1 neuraminidases.
by: Ly Le, et al.
Published: (2010-09-01) -
Studies on the Neuraminidase of Influenza Virus
by: Groome, N. P.
Published: (1975)